Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia
- 25 July 2009
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 21 (5) , 847-853
Abstract
Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a serious side effect of bisphosphonate therapy. The incidence of BRONJ is known to be low among patients treated with oral bisphosphonates. We investigated the prevalence, demographics, clinical manifestations, and treatment outcome of 24 patients with oral BRONJ in Asian populations.Keywords
This publication has 13 references indexed in Scilit:
- Bisphosphonate-Related Osteonecrosis of the Jaw: Diagnosis, Prevention, and ManagementAnnual Review of Medicine, 2009
- Pharmacovigilance and reporting oversight in US FDA fast-track process: bisphosphonates and osteonecrosis of the jawThe Lancet Oncology, 2008
- Biophosphonate-Related Osteonecrosis of the JawsDental Clinics of North America, 2008
- A Review of the Literature on Osteonecrosis of the Jaw in Patients with Osteoporosis Treated with Oral Bisphosphonates: Prevalence, Risk Factors, and Clinical CharacteristicsClinical Therapeutics, 2007
- Osteonecrosis of the jaw related to the use of bisphosphonatesCurrent Opinion in Oncology, 2007
- American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Related Osteonecrosis of the JawsJournal of Oral and Maxillofacial Surgery, 2007
- Nature and Frequency of Bisphosphonate-Associated Osteonecrosis of the Jaws in AustraliaJournal of Oral and Maxillofacial Surgery, 2007
- Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk FactorsJournal of Clinical Oncology, 2005
- Bisphosphonate-Induced Exposed Bone (Osteonecrosis/Osteopetrosis) of the Jaws: Risk Factors, Recognition, Prevention, and TreatmentJournal of Oral and Maxillofacial Surgery, 2005
- Osteonecrosis of the Jaw and BisphosphonatesNew England Journal of Medicine, 2005